43
Immunosuppressive Diseases in Commercial Chickens Frederic J. Hoerr, DVM, PhD Joint Pathology Center October 30, 2019

Immunosuppressive Diseases in Commercial Chickens

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Immunosuppressive Diseases in Commercial Chickens

Immunosuppressive Diseases in Commercial

Chickens

• Frederic J. Hoerr, DVM, PhD

• Joint Pathology Center

• October 30, 2019

Page 2: Immunosuppressive Diseases in Commercial Chickens

Bursa of Fabricius and B lymphocytes• The embryonic bursa is populated by

precursor embryonic cells from yolk sac and liver

• B Lymphocytes develop in medulla and migrate to cortex

• Most are destroyed by MHC selection• Migrate to blood stream and populate

secondary tissues• 12,000 follicles, each follicle has 2-500,000

cells

Sci Rep. 2018; 8: 16905. Published online 2018 Nov 15. doi: 10.1038/s41598-018-34897-4; Kwang Hyun Ko, et al.

Fellah et al, Avian Immunology 2nd, 2014, 45-63

Page 3: Immunosuppressive Diseases in Commercial Chickens

Thymus

• T-cells mature while traversing from cortex to medulla

• 95% of developing T lymphocytes are destroyed in development through Major Histocompatability Complex selection

• Mature T lymphocytes depart through venules at cortico-medullary junction

• Distribute to secondary lymph organs: spleen, Peyer’s patches, cecal tonsil

• Delicate balance of mature T Lymphocyte production, development, and supply to secondary organs – easily disrupted

http://bszm.elte.hu/anatomy/birds/16/

Page 4: Immunosuppressive Diseases in Commercial Chickens

SpleenPeriarteriolar lymphoid sheath (PALS), rich in T lymphocytes that are seeded by the thymus

Germinal centers composed of B Lymphocytes, seeded by the bursa, and plasma cells

Ellipsoid containing lymphocytes and reticular cells

Red pulp

Page 5: Immunosuppressive Diseases in Commercial Chickens

Recognizing Immunosuppression

• Poor/harsh vaccination responses• Exaggerated morbidity/mortality

• Early stress, later problems• Viral enteritis - Runting stunting syndrome

• Early exposure to immunosuppressive diseases• Bursal disease• Chicken infectious anemia• Marek’s disease• Newcastle• Reovirus (Viral Arthritis), Reticuloendotheliosis, ALV-J

• Diseases associated with immunosuppression• Inclusion body hepatitis, respiratory disease,

coccidiosis, gangrenous dermatitis

Page 6: Immunosuppressive Diseases in Commercial Chickens

Infectious Bursal Disease –Classical and Variant

Delaware Variant

R. W. Winterfield

Page 7: Immunosuppressive Diseases in Commercial Chickens

Very Virulent Bursal Disease (vvIBD)

Page 8: Immunosuppressive Diseases in Commercial Chickens

Chicken Infectious Anemia

Crowther et al, J Virol. 2003 77: 13036–13041 AAAP Slide Set

Blue WingAla Azul

Page 9: Immunosuppressive Diseases in Commercial Chickens

Marek’s DiseaseImmunosuppression Skin lymphoma and tumors

Page 10: Immunosuppressive Diseases in Commercial Chickens

Marek’s DiseaseImmunosuppression

Marek’s Disease Control

• Occurs at a young age• Difficult to confirm • Assume early immunosuppression if

Marek’s tumors or clinical disease are present

Page 11: Immunosuppressive Diseases in Commercial Chickens

Broiler Viral Enteritis“Runting Stunting Syndrome”

06.1029

Bursa Atrophy

Thymus Atrophy

Page 12: Immunosuppressive Diseases in Commercial Chickens

Broilers: Intestinal Virus Detection by Age

1 7 14 21 28 35 420

5

10

15

20

25

AstrovirusRotavirusReovirus

N=258 Cases

Age - Days

No.

Cas

es

Broilers: Cases by EntericViruses Detected

Astrovir

us

Rotaviru

s

Reovir

us

AstroRota

AstroReo

RotaReo

AstroRotaR

eo0

20

40

60

80

N=258 Cases

Virus

No.

Cas

es

Viral enteritis diagnosis: Retrospective PCR and Immune System Histopathology

Virus Positive Broilers <20 days:Maximum Thymus Depletion Score

RSS

Astrovir

us

Rotaviru

s

Reovir

us

AstroRota

AstroReo

RotaReo

AstroRotaR

eo0

1

2

3

4

Normal

N=131 Cases

Virus

Max

Thy

mus

Sco

re (M

ean)

Page 13: Immunosuppressive Diseases in Commercial Chickens

Day JM, Oakley BB, Seal BS, Zsak L (2015) Comparative Analysis of the Intestinal Bacterial and RNA Viral Communities from Sentinel Birds Placed on Selected Broiler Chicken Farms. PLoS ONE 10(1): e0117210. doi:10.1371/journal. pone.0117210

Enteric Virome Metagenomic Analysis: SPF Sentinals on 6 broiler farms

Page 14: Immunosuppressive Diseases in Commercial Chickens

Experimental Mycotoxicosis:Target Organs

Toxin Liver Kidney Immune Skin/Oral Other

AflatoxinSterigmatocystinCyclopiazonic acid

+++ + + +

TrichothecenesFusarochromanone

Moniliformin

+ +++ +++ ++

Ochratoxin ++ +++ + +Citrinin +++

Oosporein +++

Ergot +++ ++

DAS -Diacetoxyscirpenol

Page 15: Immunosuppressive Diseases in Commercial Chickens

Mycotoxin ImmunosuppressionToxin Lymphoid

AtrophyCell

MediatedHumoral Disease

InteractionTrichothecenes(T-2. DAS, Others) + + + +Moniliformin + +Fumonisins + +Aflatoxin + + + +Ochratoxin + + + +Citrinin +Cyclopiazonic Acid +Sterigmatocystin +

Page 16: Immunosuppressive Diseases in Commercial Chickens

Broiler, 50 days, hepatosis

• Bile duct proliferation• Differential diagnosis

• Hepatotoxic mycotoxins• Aflatoxin, cyclopiazonic acid,

sterigmatocystin• Implications

• Damaged liver• Altered hepatic processing of

nutrients• Immunosuppression

Page 17: Immunosuppressive Diseases in Commercial Chickens

Variant Reovirus -Challenge Study

VETERINARY DIAGNOSTIC PATHOLOGY, LLC 17

HeartTendon

Bursa follicular lymphoid depletion

Thymus cortex lymphoid depletion

Page 18: Immunosuppressive Diseases in Commercial Chickens

Newcastle Disease - Lymphocyte Necrosis and Depletion

Spleen ThymusCecal tonsil

Page 19: Immunosuppressive Diseases in Commercial Chickens

Stages of Bursal Disease: Histopathology• Normal Bursa

• Virus infection, acute necrotizing phase• Lymphocyte necrosis/apoptosis –rapid progression• Strain variable

• Apoptosis and lymphoid depletion, absent or minimal inflammation

• Hemorrhage, edema, granulocytic and histiocytic inflammation• Cytotoxic T cells rapidly enter and associated with decline of viral load• End point: the lymphocyte population is destroyed

• Follicular restitution phase• Absent to substantially complete• Small undifferentiated follicles, lower immunocompetence• Large differentiated follicles, higher immunocompetence

Page 20: Immunosuppressive Diseases in Commercial Chickens
Page 21: Immunosuppressive Diseases in Commercial Chickens

21

1A 2A 3A 5A

Page 22: Immunosuppressive Diseases in Commercial Chickens

Stages of Infectious Bursal Disease

Normal

Score 0Diffuse necrosis (Score 5, acute)

5

4

3 2 1

Recovery Phase

Follicular Restitution

5 Acute

Acute Phase

Page 23: Immunosuppressive Diseases in Commercial Chickens

Post Bursal Disease Follicular RestorationSmall vs. Large Follicles • Small undifferentiated

follicles• Lymphocyte restoration

from medullary stem cells• Minimal or no immune

response capability●Large follicles

– Rapidly proliferating B cells– Correlated with partial recovery of

antibody response– Withers et al. Immunology 117, 558-565,

2006– The antibody response does not occur

in the bursa– M. E. Ifrah et al. Poultry Science 96, 2017

Page 24: Immunosuppressive Diseases in Commercial Chickens

Age of Immune InjuryBursa and Thymus: Critical First 14 DaysPrimary lymphoid organs seed secondary organs

B Lymphocytes

Cecal Tonsil/GutSpleen Gland of Harder

T Lymphocytes

Page 25: Immunosuppressive Diseases in Commercial Chickens

Bursa Survey: 6 flocks – Spleen Germinal Centers (B-cell centers)

Age Units B1 B2 B3 B4 B5 B6 MeanVirus

Detect #Nec Comment

14 days 1 1 1 1 1 1 1 0 Within normal limits

21 days Tissue not available

29 days 3.5 3.5 3.5 3.5 2 2 3 2 0 Recovery IBD

34 days 3 3 3 3.5 3 1 2.75 2 0 Recovery IBD

41 days 3 3 3 3 3 1 2.6667 2 0 Recovery IBD

14 days 1 1 1 1 1 1 Within normal limits

21 days 1 1 1 1 1 1 Within normal limits

28 days 4 4 1 4 4 3.4 1 4 Acute bursitis/IBD

33 days 3.5 3.5 3.5 3 3.5 3.4 2 0 Recovery IBD

41 days 3 3 3 3 3 3 2 0 Recovery IBD

41 days 3 3 3 3 3 3 2 0 Recovery IBD

14 days 1 1 1 1 1 1 Within normal limits

21 days 4 4 3.5 1 1 2.7 1 3 Acute bursitis/IBD

28 days 4 3.5 4 3 3 3.5 2 0 Recovery IBD

33 days 3 3 3 3 3 3 2 0 Recovery IBD

41 days 2.5 3 3 3.5 3 3 2 0 Recovery IBD

14 days 1 1 1 1 1 1 Within normal limits

22 days 1 1 1 1 1 1 Within normal limits

29 days 3 3 3.5 3.5 3.5 3.3 2 0 Recovery IBD

34 days 3 3 3.5 3 3 3.1 2 0 Recovery IBD

41 days 3 3 3 3 2.5 2.9 2 0 Recovery IBD

41 days 3 2.5 3 3 3 2.9 2 0 Recovery IBD

14 days 4 1 1 1 1 1.6 1 1 Acute bursitis/IBD

21 days 3 3.5 3.5 3.5 3.5 3.4 2 0 Recovery IBD

28 days 3.5 3.5 3.5 3.5 3.5 3.5 2 0 Recovery IBD

32 days 2.5 2.5 2.5 2.5 3 2.6 2 0 Recovery IBD

41 days 2.5 2.5 2 2 2.5 2.3 2 0 Recovery IBD

41 days 1 2.5 2.5 2.5 2.5 2.2 2 0 Recovery IBD

14 days 1 1 2 1 1 1.2 1 1 Acute bursitis/IBD

21 days 4 4 4 4 3.5 3.9 1 4 Acute bursitis/IBD

28 days 3 3 3 3 3 3 2 0 Recovery IBD

33 days 2.5 4 2.5 3 3 3 2 0 Recovery IBD

41 days 2.5 2.5 1 2.5 2.5 2.2 2 0 Recovery IBD

41 days 2.5 1 2.5 2.5 2.5 2.2 2 0 Recovery IBD

25.8

16.6

18.8

11.6

4.2

7.2

Page 26: Immunosuppressive Diseases in Commercial Chickens

Thymus Pathology: Lymphocyte Depletion

0=Within Normal Limits

5=Severe

2

3

4

0

5

Page 27: Immunosuppressive Diseases in Commercial Chickens

Immune Surveys by HistopathologyOctober 2018-October 2019

• Bursa: 1438 US Broiler flocks• Thymus & Spleen ~370 flocks

• Survey designs• 21 days (bursa only)• 12 - 24 days (mostly bursa, some thymus)

• ~2 day intervals• 12 – 45 day+, bursa, also thymus and spleen

• ~3 day intervals

• 21 states and territories

• Clinically normal chickens• 5-7 birds sampled per flock• 10-15 flocks per survey

• Pathologist blinded to vaccination program

• Data in Excel, pivot table analysis

Page 28: Immunosuppressive Diseases in Commercial Chickens

Bursa by Age and Lesions

Page 29: Immunosuppressive Diseases in Commercial Chickens

Bursa by Age and Bursa Score Trends

Page 30: Immunosuppressive Diseases in Commercial Chickens

Thymus by Age and Lesions

Page 31: Immunosuppressive Diseases in Commercial Chickens

Thymus by Age and Thymus Lymphocyte Depletion Trends

Page 32: Immunosuppressive Diseases in Commercial Chickens

Bursa and Thymus Lymphoid Depletion Trends

Page 33: Immunosuppressive Diseases in Commercial Chickens

Alabama Broilers 1990’s

Lymphocytic Depletion by Age ofSubmission (N=631)

10 15 20 25 30 35 40 45 50 55 60

1.0

1.5

2.0

2.5

3.0

3.5

4.0

Bursa ThymusAge at Submission to Laboratory (Days)

Mea

n De

plet

ion

Scor

e

Page 34: Immunosuppressive Diseases in Commercial Chickens

CAV Infection& Thymus Atrophy after Depleted Maternal Immunity

• No anemia observed• Lymphocyte and macrophage suppression

• T-cell growth factor, interferon, and transformation• Macrophage FC receptor expression, interleukin-1,

phagocytosis and bactericidal activity

CAV Challenge21 4935

Maternal antibody

Immunosuppression

Age-days

1

McConnell, Adair & McNulty (Avian Dis 37:366-374, 1993)

Page 35: Immunosuppressive Diseases in Commercial Chickens

Summary of 6-year Study: Alabama Broilers CAV infection was widespread Thymus atrophy associated with CAV infection CAV, thymus atrophy, and bursa atrophy were more prevalent in chickens

with clinical disease• Respiratory• Gangrenous Dermatitis• Coccidiosis

Hagood et al. Avian Dis 44:803-808. 2000.

Laboratory findings correlated with economic losses.

Page 36: Immunosuppressive Diseases in Commercial Chickens

Thymus and Bursa Lymphocyte Depletion

Bursa Lymphocyte Depletionby Maximum Thymus Depletion

Thymus 1 Thymus 2 Thymus 3 Thymus 41

2

3

4

Kruskal-WallisP<0.0001

aa,b

b,c c

Maximum Thymus LymphocyteDepletion

Mean

Bur

saLy

mpho

cyte

Deple

tion

Page 37: Immunosuppressive Diseases in Commercial Chickens

Spleen Germinal Center Trends

Page 38: Immunosuppressive Diseases in Commercial Chickens

Spleen Germinal Center Trends by Bursal Lesions

Normal Bursa

Acute Bursitis/IBD

Page 39: Immunosuppressive Diseases in Commercial Chickens

Bursa and Spleen Interaction 20-25 days

Mean GC Normal Bursa

Mean GC Acute IBD

Minimal GC Normal Bursa

Minimal GC Acute IBD

Page 40: Immunosuppressive Diseases in Commercial Chickens

Decreased Germinal

Centers at 20-25 days

• Reduction in antibody production in spleen and other GC-rich tissues

• Gut, conjunctiva, bronchi, biliary tract

• Gut is acquiring mature function• E. maxima peak scores at 26-27 days

• Respiratory vaccine virus shedding and reaction• Potential determinate of severity of reovirus

infection (tenosynovitis)

Page 41: Immunosuppressive Diseases in Commercial Chickens

Immunosuppressive Interactions in Broilers

Bronchitis, Influenza, Paramyxovirus, LT,

Pneumovirus

Bursal Disease

Chick Anemia

E. coli, Gangrenous Dermatitis, Coccidiosis

Marek’s, Viral enteritis

Mycotoxins

Other

Permanent Immunosuppression

Transient Immunosuppression

Cost, Livability

Feed Conversion

Condemnations

14 217 28 35 42

Hatch stress

Vaccination reaction

49

Page 42: Immunosuppressive Diseases in Commercial Chickens

[email protected] South Fort Valley RdFort Valley, VA 22652

CF.320.5.Veterinary Diagnostic Pathology, LLC 42

Page 43: Immunosuppressive Diseases in Commercial Chickens

Histopathology of Broiler Disease by Age

1 7 14 28 35 4221 49 56

Omphalitis, Aspergillus, Dehydration, Ammonia

Viral Enteritis

CAV Blue Wing

IBV/PMV Vx Reaction Harsh Immuno/cycling

Rickets

E. maxima

Necrotic enteritisCAV Thymus Atrophy/T-Cell

Bursal Dis / B-Cell

Bronchitis, PMV, LT Challenge

E. coli, Salmonella E. coli, Ornithobacterium, Enterobacter

Gangrenous Dermatitis/Cellulitis

Feed change

Feed manufacture and management, water, lights, ventilation, daily care

Coccidia Vx or challenge

Viral Proventriculitis

Adenovirus - vertical Adenovirus - immunosuppression

Ascites/Synovitis/Tendonosis/DPM